Gene therapy with cytokines against cervical cancer.

被引:8
作者
Bermudez-Morales, Victor Hugo
Peralta-Zaragoza, Oscar
Madrid-Marina, Vicente
机构
[1] Inst Nacl Salud Publ, Ctr Invest Sobre Enfermedades Infecc, Cuernavaca 62502, Morelos, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2005年 / 47卷 / 06期
关键词
cervical cancer; cytokines; DNA; gene therapy; human papillomavirus;
D O I
10.1590/S0036-36342005000600011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Gene therapy is an excellent alternative for treatment of many diseases. Capacity to manipulate the DNA has allowed direct the gene therapy to correct the function of an altered gene, to increase the expression of a gene and to favour the activation of the immune response. This way, it can intend the use of the DNA like medication able to control, to correct or to cure many diseases. Gene therapy against cancer has an enormous potential, and actually the use of the DNA has increased to control diverse cancer in animal models, with very encouraging results that have allowed its applications in experimental protocols in human. This work concentrates a review of the foundations of the gene therapy and its application on cervical cancer, from the point of view of the alterations of the immune system focused on the tumour micro-environment, and the use of the cytokines as immunomodulators.
引用
收藏
页码:458 / 468
页数:11
相关论文
共 95 条
[1]
A therapy modality using recombinant IL-12 adenovirus plus E7 protein in a human papillomavirus 16 E6/E7-associated cervical cancer animal model [J].
Ahn, WS ;
Bae, SM ;
Kim, TY ;
Kim, TG ;
Lee, JM ;
Namkoong, SE ;
Kim, CK ;
Sin, JI .
HUMAN GENE THERAPY, 2003, 14 (15) :1389-1399
[2]
CANCER - THE RISE OF THE GENETIC PARADIGM [J].
BISHOP, JM .
GENES & DEVELOPMENT, 1995, 9 (11) :1309-1315
[3]
Construction and characterisation of a recombinant vaccinia was expressing human papillomavirus proteins for immunotherapy of cervical cancer [J].
Boursnell, MEG ;
Rutherford, E ;
Hickling, JK ;
Rollinson, EA ;
Munro, AJ ;
Rolley, N ;
McLean, CS ;
Borysiewicz, LK ;
Vousden, K ;
Inglis, SC .
VACCINE, 1996, 14 (16) :1485-1494
[4]
Cytotoxicity of combinations of IFN-β and chemotherapeutic drugs [J].
Brickelmaier, M ;
Carmillo, A ;
Goelz, S ;
Barsoum, J ;
Qin, XQ .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (08) :873-880
[5]
Bubeník J, 1999, INT J ONCOL, V14, P593
[6]
Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16 [J].
Bubeník, J ;
Mikysková, R ;
Vonka, V ;
Mendoza, L ;
Símová, J ;
Smahel, M ;
Indrová, M .
VACCINE, 2003, 21 (9-10) :891-896
[7]
BUBENIK J, 1994, FOLIA BIOL-PRAGUE, V40, P29
[8]
Interleukin-2 inhibits proliferation of HPV-associated tumor cells and halts tumor growth in vivo [J].
Casana, PH ;
Hernandez, H ;
Arana, MJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (05) :818-824
[9]
Chang EY, 2000, INT J CANCER, V86, P725, DOI 10.1002/(SICI)1097-0215(20000601)86:5<725::AID-IJC19>3.3.CO
[10]
2-B